HK1010698A1 - Plasma-like solution - Google Patents

Plasma-like solution

Info

Publication number
HK1010698A1
HK1010698A1 HK98111830A HK98111830A HK1010698A1 HK 1010698 A1 HK1010698 A1 HK 1010698A1 HK 98111830 A HK98111830 A HK 98111830A HK 98111830 A HK98111830 A HK 98111830A HK 1010698 A1 HK1010698 A1 HK 1010698A1
Authority
HK
Hong Kong
Prior art keywords
solution
plasma
disclosed
dextran
administration
Prior art date
Application number
HK98111830A
Other languages
English (en)
Inventor
Paul E Segall
Hal Sternberg
Harold D Waitz
Judith M Segall
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26752331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010698(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/071,533 external-priority patent/US5407428A/en
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of HK1010698A1 publication Critical patent/HK1010698A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK98111830A 1993-06-04 1998-11-09 Plasma-like solution HK1010698A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/071,533 US5407428A (en) 1993-06-04 1993-06-04 Solutions for use as plasma expanders and substitutes
US13352793A 1993-10-07 1993-10-07
PCT/US1994/006279 WO1994028950A1 (en) 1993-06-04 1994-06-03 Plasma-like solution

Publications (1)

Publication Number Publication Date
HK1010698A1 true HK1010698A1 (en) 1999-06-25

Family

ID=26752331

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98111830A HK1010698A1 (en) 1993-06-04 1998-11-09 Plasma-like solution

Country Status (17)

Country Link
US (14) US5702880A (ru)
EP (1) EP0701455B1 (ru)
JP (1) JP3715312B2 (ru)
KR (1) KR100267604B1 (ru)
CN (1) CN1102851C (ru)
AT (1) ATE199626T1 (ru)
AU (1) AU681675B2 (ru)
BR (1) BR9406742A (ru)
CA (1) CA2164321C (ru)
DE (1) DE69426879T2 (ru)
DK (1) DK0701455T3 (ru)
ES (1) ES2157260T3 (ru)
GR (1) GR3036013T3 (ru)
HK (1) HK1010698A1 (ru)
PT (1) PT701455E (ru)
RU (1) RU2142282C1 (ru)
WO (1) WO1994028950A1 (ru)

Families Citing this family (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU681675B2 (en) * 1993-06-04 1997-09-04 Biotime, Inc. Plasma-like solution
US5945272A (en) * 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US6300322B1 (en) 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US6627393B2 (en) * 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
WO1999022746A1 (en) * 1997-10-31 1999-05-14 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US7166084B2 (en) * 1996-09-23 2007-01-23 Dsu Medical Corporation Blood set priming method and apparatus
US6387069B1 (en) * 1996-09-23 2002-05-14 Dsu Medical Corporation Blood set priming method and apparatus
US5804551A (en) * 1996-11-12 1998-09-08 Baxter International Inc. Pretraumatic use of hemoglobin
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
DE69831248T2 (de) * 1997-02-28 2006-04-13 The Regents Of The University Of California, Oakland Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
WO1998041156A1 (en) * 1997-03-17 1998-09-24 Boris Rubinsky The use of cryoprotective agent compounds during cryosurgery
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6117166A (en) * 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue
CN1068778C (zh) * 1998-05-15 2001-07-25 赵超英 救治用的药物组合物及其制备方法
US6706309B1 (en) 1998-11-25 2004-03-16 William F. Aftoora Liquefied water soluble acidity-reducing formulation for food and beverage products
WO2000030476A1 (en) * 1998-11-25 2000-06-02 Aftoora William F Liquefied water soluble acidity-reducing formulation for food and beverage products
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6755811B1 (en) * 1999-08-25 2004-06-29 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
US6759230B1 (en) * 1999-10-26 2004-07-06 The Board Of Regents, The University Of Texas Microbe, microbial exopolysaccharide, and uses thereof
US6492103B1 (en) 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
PT1398038E (pt) * 2000-02-08 2007-02-28 Allergan Inc Composições farmacêuticas de toxina botulínica
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
AU2001255339A1 (en) * 2000-04-14 2001-10-30 Biotime, Inc. Systems, kits, and methods of administering synthetic plasma
AU2001279073B2 (en) * 2000-07-28 2006-08-24 Christopher J. Murphy Transplant media
ES2263674T5 (es) * 2000-11-03 2011-04-01 Xvivo Perfusion Ab Disolución de evaluación y conservación .
US6746836B1 (en) 2000-12-08 2004-06-08 Abe Widra Alpha-keratose as a blood plasma expander and use thereof
US6864231B2 (en) * 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US6806069B2 (en) 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
JP2004527529A (ja) * 2001-04-04 2004-09-09 クリティカル セラピューティックス インコーポレイテッド 急性腎不全を予防するための方法
WO2002101018A2 (en) * 2001-06-11 2002-12-19 Fred Hutchinson Cancer Research Center Methods for inducing reversible stasis
US20070213793A1 (en) * 2001-08-06 2007-09-13 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
ATE411058T1 (de) 2001-10-25 2008-10-15 Univ Emory Katheter für modifizierte perfusion
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
EP1494659B1 (en) * 2002-04-17 2005-10-12 Critical Therapeutics, Inc. Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US20070029259A1 (en) * 2003-02-04 2007-02-08 Hirotaka Kakita Method of reducing impurity content in aqueous salt solution
ES2274438T3 (es) * 2003-05-01 2007-05-16 Innogene Kalbiotech Pte. Ltd. Uso de una compsicion farmaceutica que contiene acido lactico o lactato y potasio para tratar edema cerebral o lesiones cerebrales.
ZA200608126B (en) * 2004-03-01 2008-02-27 Braun Melsungen Ag Hydroxyethyl starch
GB0407583D0 (en) * 2004-04-05 2004-05-05 Arbab Tarig S M Diagnostic testing and related matters
WO2007001339A2 (en) * 2004-08-17 2007-01-04 Wake Forest University Health Sciences Ambient stored blood plasma expanders
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
IL311989A (en) 2004-10-07 2024-06-01 Transmedics Inc Methods and systems for extracorporeal organ treatment
US20080097385A1 (en) * 2004-12-22 2008-04-24 Jakob Vinten-Johansen Therapeutic Adjuncts to Enhance the Organ Protective Effects of Postconditioning
JP2008538752A (ja) * 2005-04-12 2008-11-06 クレオ コスメティック アンド ファーマスーティカルカンパニー エルエルシー 角膜組織を生体外保存するための組成物および方法
MX2007013196A (es) * 2005-04-20 2008-01-18 Hutchinson Fred Cancer Res Metodos, composiciones y articulos de fabricacion para mejorar la supervivencia de celulas, tejidos, organos y organismos.
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
JP5246398B2 (ja) * 2005-11-08 2013-07-24 味の素株式会社 麻酔覚醒促進剤
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
AU2006341414A1 (en) * 2006-04-03 2007-10-11 Innogene Kalbiotech Pte Ltd Lactate and calcium containing pharmaceutical composition and uses thereof
ES2625850T3 (es) 2006-04-19 2017-07-20 Transmedics, Inc. Procedimientos para el cuidado de órganos ex vivo
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US20080077201A1 (en) 2006-09-26 2008-03-27 Juniper Medical, Inc. Cooling devices with flexible sensors
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
GB0712833D0 (en) * 2007-07-03 2007-08-08 Aqix Ltd Body Fluid Expander
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
EP3488833A1 (en) 2007-08-21 2019-05-29 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US9247728B2 (en) 2008-01-31 2016-02-02 Transmedics, Inc. Systems and methods for ex vivo lung care
US20090263780A1 (en) * 2008-04-17 2009-10-22 Yanming Wang Organ preservation fluid
EP2346428B1 (en) 2008-09-25 2019-11-06 Zeltiq Aesthetics, Inc. Treatment planning systems and methods for body contouring applications
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
CN101444526B (zh) * 2008-12-30 2012-06-27 杭州民生药业有限公司 一种药物组合物
BRPI1014623B1 (pt) 2009-04-30 2020-01-07 Zeltiq Aesthetics, Inc. Sistema para tratamento de celulas subcutâneas ricas em lipídeos em uma área alvo
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DE102009045589A1 (de) * 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
US9314368B2 (en) 2010-01-25 2016-04-19 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods
WO2011160012A1 (en) * 2010-06-17 2011-12-22 The Trustees Of Columbia University In The City Of New York Tissue culture media containing trimethylamine n-oxide
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
IT1401386B1 (it) * 2010-07-30 2013-07-18 Eurotech S P A Dispositivo di raffreddamento a liquido per schede elettroniche, in particolare per unita' di elaborazione ad elevate prestazioni
GB201020300D0 (en) 2010-11-30 2011-01-12 Vitrolife Sweden Ab Product
US10722395B2 (en) 2011-01-25 2020-07-28 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US9253976B2 (en) 2011-03-15 2016-02-09 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US8828710B2 (en) 2011-03-15 2014-09-09 Paragonix Technologies, Inc. System for hypothermic transport of samples
US20210392873A1 (en) 2011-03-15 2021-12-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
CA2830225C (en) 2011-03-15 2020-03-24 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
WO2012142487A1 (en) 2011-04-14 2012-10-18 Transmedics, Inc. Organ care solution for ex-vivo machine perfusion of donor lungs
CN102488942B (zh) * 2011-11-22 2013-03-20 安徽双鹤药业有限责任公司 回血试验方法及其回血试验装置
US20130330706A1 (en) * 2012-06-06 2013-12-12 Evan C. Unger Fluid for Suspended Animation
US8785116B2 (en) 2012-08-10 2014-07-22 Paragonix Technologies, Inc. Methods for evaluating the suitability of an organ for transplant
US9560846B2 (en) 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
EP3099258B1 (en) 2014-01-31 2024-02-21 Zeltiq Aesthetics, Inc. Compositions and treatment systems for improved cooling of lipid-rich tissue
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
CN106659151B (zh) 2014-06-02 2021-06-08 特兰斯迈迪茨公司 离体器官护理系统
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
CA2970117A1 (en) 2014-12-12 2016-06-16 Darren FREED Apparatus and method for organ perfusion
CA2988610A1 (en) * 2015-06-10 2016-12-15 Cellphire, Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
JP7043392B2 (ja) * 2015-08-18 2022-03-29 アステラス インスティテュート フォー リジェネレイティブ メディシン 臨床製剤
CN112933394B (zh) 2015-09-09 2023-10-24 特兰斯迈迪茨公司 用于在离体器官护理系统中使用的主动脉插管
US10448631B2 (en) 2015-09-22 2019-10-22 East Carolina University Cryopreservation using sucralose
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
EP3399950A1 (en) 2016-01-07 2018-11-14 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
CN106092848B (zh) * 2016-03-22 2018-07-06 威海威高血液净化制品有限公司 透析器超滤性能测试液
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
AU2016431615A1 (en) * 2016-12-08 2019-06-20 Cellphire, Inc. Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
WO2018226993A1 (en) 2017-06-07 2018-12-13 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
AU2019315940A1 (en) 2018-07-31 2021-03-04 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
US20200224164A1 (en) 2018-11-30 2020-07-16 Cellphire, Inc. Platelets as delivery agents
EP3886879A4 (en) 2018-11-30 2022-12-07 Cellphire Inc. PLATES AS DELIVERY AGENTS
CN113795247B (zh) 2018-12-14 2024-04-05 陈益祥 用于心脏手术的稳定心脏麻痹液
WO2020227149A1 (en) 2019-05-03 2020-11-12 Cellphire, Inc. Materials and methods for producing blood products
EP3975948A4 (en) 2019-06-03 2023-06-28 Cooler Heads Care, Inc. Cooling cap assembly and cooling unit
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN ANTI-PLATELET DEACTIVATING AGENT
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
WO2021158622A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Anti-fibrinolytic loaded platelets
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
IT202000027050A1 (it) * 2020-11-12 2022-05-12 S A L F S P A Laboratorio Farm Soluzione colloidale per la perfusione e la conservazione ex-vivo dei polmoni
USD1031028S1 (en) 2022-09-08 2024-06-11 Paragonix Technologies, Inc. Tissue suspension adaptor

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34077A (en) * 1862-01-07 Improvement in weighing-registers
US3356570A (en) * 1964-11-27 1967-12-05 Trustees Of Barnes Hospital Composition for treating shock
US3758382A (en) * 1968-07-26 1973-09-11 Us Navy Ve agent process of freezing blood using a hydroxyalkyl starch as cryoprotecti
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
US3897550A (en) * 1971-06-01 1975-07-29 Cybersol Method for administering water soluble drugs, nutrients and other solutes to a mammal
US3937821A (en) * 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4609372A (en) * 1983-10-13 1986-09-02 Miles Laboratories, Inc. Heat sterilizable storage solution for red blood cells
EP0179879A1 (en) * 1984-04-27 1986-05-07 Synthetic Blood Corporation A substitute for human blood and a method of making the same
US4663166A (en) * 1984-06-22 1987-05-05 Veech Richard L Electrolyte solutions and in vivo use thereof
US5084377A (en) * 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) * 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
WO1989005659A1 (en) * 1987-12-24 1989-06-29 Borody Thomas J Orthostatic lavage solutions
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5082831A (en) * 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
WO1991015215A1 (en) * 1990-03-30 1991-10-17 Biomedical Frontiers, Inc. Fluid resuscitation
US5416078A (en) * 1990-03-30 1995-05-16 Biomedical Frontiers, Inc. Fluid resuscitation
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
GB9021325D0 (en) * 1990-10-01 1990-11-14 Geistlich Soehne Ag Chemical composition
EP0510185B1 (en) * 1990-11-07 1996-12-11 Baxter International Inc. Blood platelet storage medium
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
WO1993002653A1 (en) * 1991-08-08 1993-02-18 Segel Leigh D Fluorocarbon blood substitute
AU681675B2 (en) * 1993-06-04 1997-09-04 Biotime, Inc. Plasma-like solution
US5407428A (en) 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes

Also Published As

Publication number Publication date
AU7052594A (en) 1995-01-03
JPH08511265A (ja) 1996-11-26
CN1127476A (zh) 1996-07-24
US5613944A (en) 1997-03-25
EP0701455A1 (en) 1996-03-20
US5698536A (en) 1997-12-16
DE69426879D1 (de) 2001-04-19
US5702880A (en) 1997-12-30
US6444418B2 (en) 2002-09-03
PT701455E (pt) 2001-09-27
DE69426879T2 (de) 2001-10-18
US6406839B1 (en) 2002-06-18
BR9406742A (pt) 1996-03-12
US6080538A (en) 2000-06-27
US20020009783A1 (en) 2002-01-24
AU681675B2 (en) 1997-09-04
US5747071A (en) 1998-05-05
US20020025562A1 (en) 2002-02-28
ATE199626T1 (de) 2001-03-15
US5571801A (en) 1996-11-05
US6410218B2 (en) 2002-06-25
CN1102851C (zh) 2003-03-12
WO1994028950A1 (en) 1994-12-22
CA2164321C (en) 2002-08-20
DK0701455T3 (da) 2001-06-18
EP0701455A4 (en) 1998-01-07
JP3715312B2 (ja) 2005-11-09
EP0701455B1 (en) 2001-03-14
US5733894A (en) 1998-03-31
GR3036013T3 (en) 2001-09-28
RU2142282C1 (ru) 1999-12-10
ES2157260T3 (es) 2001-08-16
CA2164321A1 (en) 1994-12-22
US20020012957A1 (en) 2002-01-31
US6387612B1 (en) 2002-05-14
KR100267604B1 (ko) 2000-11-01
US5723281A (en) 1998-03-03
US6110504A (en) 2000-08-29
US5968726A (en) 1999-10-19

Similar Documents

Publication Publication Date Title
GR3036013T3 (en) Plasma-like solution
US5145771A (en) Rinse solution for organs and tissues
KR890009409A (ko) 기관 보존 및 저장에 적당한 조성물 및 기관 보조 방법
ATE235813T1 (de) Verfahren zur vorbereitung von organen auf die kryokonservierung
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
EP1552846A3 (en) Use of heparinases to decrease inflammatory responses
KR100855354B1 (ko) 관류세척 보존 용액
Hällgren et al. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats.
DE69911172D1 (de) Steriler komplex eines therapeutischen peptids an ein polysaccharid
EP1150728A4 (en) METHODS AND COMPOSITIONS FOR USE IN INFUSION APPLICATIONS
HUP9900112A2 (hu) Tartósító oldat
Jönsson et al. Cardiac muscle cell damage induced by restraint stress
Klotz The adherence of Candida yeasts to human and bovine vascular endothelium and subendothelial extracellular matrix
US5556842A (en) Method for viable preservation of lung grafts
CA2266012A1 (en) Flush-storage solution for donor organs
WO1989010746A3 (en) Blood substitute
Brezis et al. Hypoxic injury to medullary thick ascending limbs in perfused rat kidneys: reversible and irreversible phases
Mansi et al. Repeat administration of high dose melphalan in relapsed myeloma
ITMI922950A1 (it) Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
CA2389896A1 (en) Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
JPH11246301A (ja) 臓器保存溶液
CA2086835A1 (en) Tissue plasminogen activator variants with decreased clearance
EP0295826A1 (en) Method of using superoxide dismutase during surgical procedures
Barner Allogenic vein as a conduit for coronary artery bypass
BG104385A (en) Physiologically acceptable aqueous solutions and methods for their application

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20140602